Outcome of patients treated with pentostatin as salvage therapy of steroid refractory acute intestinal graft-versus-host disease

被引：0
|
作者：
Klein, SA [1 ]
Bug, G [1 ]
Wassmann, B [1 ]
Hoelzer, D [1 ]
Martin, H [1 ]
机构：
[1] Univ Frankfurt Klinikum, D-6000 Frankfurt, Germany
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [41] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [42] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
    Trenschel, R
    Trampenau, C
    Ditschkowski, M
    Elmaagacli, A
    Ottinger, H
    Steckel, N
    Biersack, H
    Peceny, R
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
  • [43] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [44] Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
    Pidala, Joseph
    Kim, Jongphil
    Field, Teresa
    McBride, Ali
    Kharfan-Dabaja, Mohamed
    Perkins, Janelle
    Fernandez, Hugo
    Perez, Lia
    Ayala, Ernesto
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1116 - 1121
  • [45] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [46] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
  • [47] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [48] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [49] Novel strategies for steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Vogelsang, GB
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 40 - 44
  • [50] Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillenmo J.
    Tarin-Arzaga, Luz del Carmen
    Gonzalez-Llano, Oscar
    Gutierrez-Aguirre, Homero
    Cantu-Rodriguez, Olga
    Jaime-Perez, Jose
    Carrasco-Yalan, Antonio
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 10 - 15
12345